Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $2.52 Million - $2.79 Million
-10,784 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $2.39 Million - $2.79 Million
10,784 New
10,784 $1.35 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Resource Planning Group Portfolio

Follow Resource Planning Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resource Planning Group, based on Form 13F filings with the SEC.

News

Stay updated on Resource Planning Group with notifications on news.